Lv11
80 积分 2024-09-06 加入
Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma
2小时前
已完结
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
2个月前
已完结
Potential future direction of measurable residual disease evaluation in multiple myeloma
3个月前
已关闭
Potential future direction of measurable residual disease evaluation in multiple myeloma
3个月前
已关闭
Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice
3个月前
已完结
Diagnosis and Management of Multiple Myeloma
3个月前
已完结
How I manage mantle cell lymphoma: indolent versus aggressive disease
4个月前
已完结
Challenges in chimeric antigen receptor-T cell product administration in a high tumor-burden elderly patient with mantle-cell lymphoma
4个月前
已完结
Metabolic and toxicological considerations of Bruton’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
4个月前
已完结
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms
4个月前
已完结
皖公网安备34019202002308
